HIRSCHMAN ORIN 13D and 13G filings for Salarius Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-11 7:15 pm Sale |
2021-01-04 | 13G | Salarius Pharmaceuticals, Inc. SLRX |
HIRSCHMAN ORIN | 5,833 4.990% |
-254 (-4.17%) |
Filing |